Invention Grant
- Patent Title: Antibodies binding to α7β1 integrin antibodies and compositions thereof
-
Application No.: US17098199Application Date: 2020-11-13
-
Publication No.: US12134642B2Publication Date: 2024-11-05
- Inventor: Patrick Andre , Chun Chen , Scott Turner
- Applicant: Pliant Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Pliant Therapeutics, Inc.
- Current Assignee: Pliant Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- Agent Kraig Anderson; Johannes Hull
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K39/00 ; A61K39/395 ; A61K45/06 ; A61P25/28 ; C07K16/00 ; C07K16/28
Abstract:
Disclosed herein are pharmaceutical agents and compositions that activate integrin heterodimers that contain beta-1 integrin protein that specifically bind laminin protein. Such agents and compositions are useful for treating diseases related to muscle malfunction, including muscular dystrophies.
Public/Granted literature
- US20210147526A1 COMPOSITIONS AND METHODS FOR ACTIVATION OF INTEGRINS Public/Granted day:2021-05-20
Information query
